Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Leap Therapeutics Inc (LPTX)
Add to/Remove from a Portfolio
Add to Watchlist
2.9600
-0.0400
-1.33%
After Hours
3.0300
+0.0700
+2.3649%
18/04
Type:
Equity
Market:
United States
- Volume: 100,757
- Bid/Ask: 2.8000 / 3.4000
- Day's Range: 2.8900 - 3.0600
Leap Therapeutics
2.9600
-0.0400
-1.33%
- Discussions
- Recent Sentiments
- User Rankings
LPTX User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Leap Therapeutics Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Jordan Macdonald | 2 | 2 | 2 | 100 | +33.87% |
| 2 | Jeremy Swainston | 1 | 1 | 1 | 100 | +33.33% |
| 3 | Josh Thompson | 1 | 1 | 1 | 100 | +29.74% |
| 4 | davide garulli | 1 | 1 | 1 | 100 | +28.57% |
| 5 | Abdulrhmman Talal | 1 | 1 | 1 | 100 | +26.28% |
| 6 | Alexandre Bavastro | 1 | 1 | 1 | 100 | +18.24% |
| 7 | Alfie Brock | 1 | 1 | 1 | 100 | +15.43% |
| 8 | Devin Porter | 1 | 1 | 1 | 100 | +11.49% |
| 9 | Sandy Bananas | 1 | 1 | 1 | 100 | +10.95% |
| 10 | Marcell Nagynemes | 1 | 1 | 1 | 100 | +8.94% |
| 11 | Angel Fernandez | 1 | 1 | 1 | 100 | +8.47% |
| 12 | Hmoob Hmong | 1 | 1 | 1 | 100 | +8.45% |
| 13 | Rex R | 1 | 1 | 1 | 100 | +4.84% |
| 14 | husin mohd | 1 | 1 | 1 | 100 | +3.91% |
| 15 | Anita Vacca | 1 | 1 | 1 | 100 | +2.35% |
| 16 | Raul Muñoz | 4 | 4 | 2 | 50 | +1.53% |
| 17 | Владимир Бобачев | 1 | 1 | 1 | 100 | +1.12% |
| 18 | Sergen Yaglıcı | 1 | 1 | 1 | 100 | +0.68% |
| 19 | Arend Wolven | 1 | 1 | 1 | 100 | +0.67% |
| 20 | Giovanni Colli | 1 | 1 | 1 | 100 | +0.67% |
| 21 | David Ramos Quirós | 1 | 1 | 0 | 0 | 0% |
| 22 | Cristal Morada | 1 | 1 | 0 | 0 | -0.67% |
| 23 | Kenneth Williams | 1 | 1 | 0 | 0 | -0.68% |
| 24 | Dan Nguyen | 1 | 1 | 0 | 0 | -2.84% |
| 25 | Lorena Curvelo | 1 | 1 | 0 | 0 | -6.7% |
| 26 | Nick Ramos | 1 | 1 | 0 | 0 | -7.02% |
| 27 | Fatih Doğan | 1 | 1 | 0 | 0 | -8.45% |
| 28 | Gabriel Pita | 1 | 1 | 0 | 0 | -9.47% |
| 29 | Tique Huynh | 1 | 1 | 0 | 0 | -11.46% |
| 30 | ST ZR | 1 | 1 | 0 | 0 | -12.21% |
| 31 | Robbert Kuipers | 1 | 1 | 0 | 0 | -12.95% |
| 32 | Patrick Yuan | 1 | 1 | 0 | 0 | -13.57% |
| 33 | Roberto Fanone | 1 | 1 | 0 | 0 | -15.22% |
| 34 | Alexandre Bavastro | 2 | 1 | 0 | 0 | -17.39% |
| 35 | Nathan Chavez | 1 | 1 | 0 | 0 | -17.72% |
| 36 | Andre White | 1 | 1 | 0 | 0 | -18.1% |
| 37 | Gavin Browne | 1 | 1 | 0 | 0 | -18.48% |
| 38 | أسامه عل علي | 1 | 1 | 0 | 0 | -20.26% |
| 39 | Kawa Uzan | 1 | 1 | 0 | 0 | -23.12% |
| 40 | Jasmine Fields | 1 | 1 | 0 | 0 | -26.25% |
| 41 | Alexis LEVY | 1 | 1 | 0 | 0 | -27.73% |
| 42 | jul ger | 1 | 1 | 0 | 0 | -28.03% |
| 43 | David Klempíř | 1 | 1 | 0 | 0 | -33.78% |
| 44 | Francis Collette | 1 | 1 | 0 | 0 | -36.53% |
| 45 | Trifon Gutierrez | 1 | 1 | 0 | 0 | -37% |
| 46 | Suzanne Lindgren | 1 | 1 | 0 | 0 | -37% |
| 47 | Claudio Cola | 1 | 1 | 0 | 0 | -43.55% |
| 48 | Nikolaos Gkasios | 1 | 1 | 0 | 0 | -47.06% |
| 49 | Jay Siva | 1 | 1 | 0 | 0 | -48.85% |
Write your thoughts about Leap Therapeutics Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review